Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1974 3
1975 2
1976 1
1977 3
1978 3
1979 1
1980 3
1981 1
1982 2
1984 1
1985 3
1986 7
1987 5
1988 1
1989 1
1990 5
1991 6
1992 6
1993 5
1994 1
1995 3
1997 4
1998 1
1999 3
2000 5
2001 3
2002 6
2003 6
2004 9
2005 10
2006 9
2007 9
2008 11
2009 3
2010 5
2011 8
2012 12
2013 6
2014 22
2015 16
2016 15
2017 15
2018 14
2019 10
2020 11
2021 12
2022 13
2023 18
2024 33
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Results by year

Filters applied: . Clear all
Page 1
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL, Davey R, Montgomery R, Ruben J, Foroudi F, Higgs B, Lin C, Raman A, Hardcastle N, Hofman MS, De Abreu Lourenco R, Shaw M, Mancuso P, Moon D, Wong LM, Lawrentschuk N, Wood S, Brook NR, Kron T, Martin J, Pryor D; FASTRACK II Investigator Group. Siva S, et al. Lancet Oncol. 2024 Mar;25(3):308-316. doi: 10.1016/S1470-2045(24)00020-2. Lancet Oncol. 2024. PMID: 38423047 Clinical Trial.
Protein-Based Nanohydrogels for Bioactive Delivery.
Chander S, Kulkarni GT, Dhiman N, Kharkwal H. Chander S, et al. Front Chem. 2021 Jul 9;9:573748. doi: 10.3389/fchem.2021.573748. eCollection 2021. Front Chem. 2021. PMID: 34307293 Free PMC article. Review.
West Nile virus infection.
Zak IT, Altinok D, Merline JR, Chander S, Kish KK. Zak IT, et al. Among authors: chander s. AJR Am J Roentgenol. 2005 Mar;184(3):957-61. doi: 10.2214/ajr.184.3.01840957. AJR Am J Roentgenol. 2005. PMID: 15728624 Review.
Anti-infective Potential of Manzamine Alkaloids - A Review.
Ashok P, Faheem, Kumar BK, Chander S, Chandra Sekhar KVG, Sankaranarayanan M. Ashok P, et al. Among authors: chander s. Med Chem. 2022;18(6):629-654. doi: 10.2174/1573406417666210803101740. Med Chem. 2022. PMID: 34344295 Review.
Radiation induced liver disease: A clinical update.
Benson R, Madan R, Kilambi R, Chander S. Benson R, et al. Among authors: chander s. J Egypt Natl Canc Inst. 2016 Mar;28(1):7-11. doi: 10.1016/j.jnci.2015.08.001. Epub 2015 Aug 20. J Egypt Natl Canc Inst. 2016. PMID: 26300327 Free article. Review.
342 results